Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)

Karolin Ebert; Gwen Zwingenberger; Elena Barbaria; Simone Keller; Corinna Heck; Rouven Arnold; Vanessa Hollerieth; Julian Mattes; Robert Geffers; Elba Raimúndez; Jan Hasenauer; Birgit Luber

doi:10.1186/s12885-020-07642-2

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)

Karolin Ebert, Gwen Zwingenberger, Elena Barbaria, Simone Keller, Corinna Heck, Rouven Arnold, Vanessa Hollerieth, Julian Mattes, Robert Geffers, Elba Raimúndez, Jan Hasenauer, Birgit Luber

Lehrstuhl für Pathologie

Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

Abstract

Following publication of the original article [1], the authors reported an error in the labeling of Table 5. The corrected Table 5 is given below.

Originalsprache	Englisch
Aufsatznummer	1127
Fachzeitschrift	BMC Cancer
Jahrgang	20
Ausgabenummer	1
DOIs	https://doi.org/10.1186/s12885-020-07642-2
Publikationsstatus	Veröffentlicht - Dez. 2020

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1186/s12885-020-07642-2

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren

Ebert, K., Zwingenberger, G., Barbaria, E., Keller, S., Heck, C., Arnold, R., Hollerieth, V., Mattes, J., Geffers, R., Raimúndez, E., Hasenauer, J., & Luber, B. (2020). Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7). BMC Cancer, 20(1), Artikel 1127. https://doi.org/10.1186/s12885-020-07642-2

@article{92a73885e6904a588802720f5612dfd0,

title = "Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)",

abstract = "Following publication of the original article [1], the authors reported an error in the labeling of Table 5. The corrected Table 5 is given below.",

author = "Karolin Ebert and Gwen Zwingenberger and Elena Barbaria and Simone Keller and Corinna Heck and Rouven Arnold and Vanessa Hollerieth and Julian Mattes and Robert Geffers and Elba Raim{\'u}ndez and Jan Hasenauer and Birgit Luber",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

doi = "10.1186/s12885-020-07642-2",

language = "English",

volume = "20",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

number = "1",

}

Ebert, K, Zwingenberger, G, Barbaria, E, Keller, S, Heck, C, Arnold, R, Hollerieth, V, Mattes, J, Geffers, R, Raimúndez, E, Hasenauer, J & Luber, B 2020, 'Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)', BMC Cancer, Jg. 20, Nr. 1, 1127. https://doi.org/10.1186/s12885-020-07642-2

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7). / Ebert, Karolin; Zwingenberger, Gwen; Barbaria, Elena et al.
in: BMC Cancer, Jahrgang 20, Nr. 1, 1127, 12.2020.

Publikation: Beitrag in Fachzeitschrift › Kommentar/Debatte

TY - JOUR

T1 - Correction to

T2 - Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7)

AU - Ebert, Karolin

AU - Zwingenberger, Gwen

AU - Barbaria, Elena

AU - Keller, Simone

AU - Heck, Corinna

AU - Arnold, Rouven

AU - Hollerieth, Vanessa

AU - Mattes, Julian

AU - Geffers, Robert

AU - Raimúndez, Elba

AU - Hasenauer, Jan

AU - Luber, Birgit

PY - 2020/12

Y1 - 2020/12

N2 - Following publication of the original article [1], the authors reported an error in the labeling of Table 5. The corrected Table 5 is given below.

AB - Following publication of the original article [1], the authors reported an error in the labeling of Table 5. The corrected Table 5 is given below.

UR - http://www.scopus.com/inward/record.url?scp=85096360821&partnerID=8YFLogxK

U2 - 10.1186/s12885-020-07642-2

DO - 10.1186/s12885-020-07642-2

M3 - Comment/debate

C2 - 33225928

AN - SCOPUS:85096360821

SN - 1471-2407

VL - 20

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 1127

ER -